TY - JOUR
T1 - Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice
T2 - results from the nationwide Danish DANBIO registry
AU - Leffers, Henrik Christian
AU - Østergaard, Mikkel
AU - Glintborg, Bente
AU - Krogh, Niels Steen
AU - Henriksen, Heidi Foged
AU - Tarp, Ulrik
AU - Lorenzen, Tove
AU - Hansen, Annette
AU - Hansen, Michael Sejer
AU - Jacobsen, Martin Skov
AU - Dreyer, Lene
AU - Hetland, Merete Lund
AU - Denmark, all departments of rheumatology in
PY - 2011
Y1 - 2011
N2 - To describe drug survival, disease activity and clinical response in patients with rheumatoid arthritis (RA) treated with abatacept or tocilizumab in routine care, based on prospectively registered observational data from the nationwide Danish DANBIO registry.
AB - To describe drug survival, disease activity and clinical response in patients with rheumatoid arthritis (RA) treated with abatacept or tocilizumab in routine care, based on prospectively registered observational data from the nationwide Danish DANBIO registry.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Antibodies, Monoclonal
KW - Antibodies, Monoclonal, Humanized
KW - Antirheumatic Agents
KW - Arthritis, Rheumatoid
KW - C-Reactive Protein
KW - Epidemiologic Methods
KW - Female
KW - Humans
KW - Immunoconjugates
KW - Male
KW - Medication Adherence
KW - Middle Aged
KW - Treatment Outcome
KW - Tumor Necrosis Factor-alpha
KW - Young Adult
U2 - 10.1136/ard.2010.140129
DO - 10.1136/ard.2010.140129
M3 - Journal article
SN - 0003-4967
VL - 70
SP - 1216
EP - 1222
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 7
ER -